Access
To read this story in full you will need to login or make a payment (see right).
Article
Nature 429, 834-840 (24 June 2004) | doi:10.1038/nature02592; Received 8 March 2004; Accepted 21 April 2004
Open Innovation Challenges
-
Optimizing Sub-cellular Localization Tags
The Seeker is looking for methods to optimize sub-cellular localization tags for protein expression....
-
Single-cell Analysis Platform
This Challenge is looking for novel approaches to analyzing changes at a single-cell level. This is...
nature jobs
Senior Computational Scientist
- Argonne National Laboratory
- Argonne, IL, United States
Scientist / Sr. Scientist - Biopharmaceutics
- Syngene International
- Bangalore, Karnataka 560099 India
A membrane protein required for dislocation of misfolded proteins from the ER
Brendan N. Lilley1 & Hidde L. Ploegh1
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA
Correspondence to: Hidde L. Ploegh1 Email: ploegh@hms.harvard.edu
Abstract
After insertion into the endoplasmic reticulum (ER), proteins that fail to fold there are destroyed. Through a process termed dislocation such misfolded proteins arrive in the cytosol, where ubiquitination, deglycosylation and finally proteasomal proteolysis dispense with the unwanted polypeptides. The machinery involved in the extraction of misfolded proteins from the ER is poorly defined. The human cytomegalovirus-encoded glycoproteins US2 and US11 catalyse the dislocation of class I major histocompatibility complex (MHC) products, resulting in their rapid degradation. Here we show that US11 uses its transmembrane domain to recruit class I MHC products to a human homologue of yeast Der1p, a protein essential for the degradation of a subset of misfolded ER proteins. We show that this protein, Derlin-1, is essential for the degradation of class I MHC molecules catalysed by US11, but not by US2. We conclude that Derlin-1 is an important factor for the extraction of certain aberrantly folded proteins from the mammalian ER.
- Department of Pathology, Harvard Medical School, Boston, Massachusetts, 02115, USA
Correspondence to: Hidde L. Ploegh1 Email: ploegh@hms.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Research HighlightsNature Structural & Molecular Biology News and Views (01 Mar 2006)
Lectins sweet-talk proteins into ERADNature Cell Biology News and Views (01 Mar 2008)
See all 6 matches for News And ViewsRESEARCH
Autologous hematopoietic stem cell transplantation for breast cancer in Europe: critical evaluation of data from the European Group for Blood and Marrow Transplantation (EBMT) Registry 1990?1999Bone Marrow Transplantation Original Article
A glycosylated type I membrane protein becomes cytosolic when peptide: N-glycanase is compromisedThe EMBO Journal Article (11 Feb 2004)
See all 48 matches for Research
